FDA warns about risk of unapproved stem cell therapy
The FDA's recent inspection revealed that the Stemell was manufacturing products derived from human umbilical cord blood and…
04 Sep 19
The FDA's recent inspection revealed that the Stemell was manufacturing products derived from human umbilical cord blood and…
09 Aug 19
Adherence to FDA quality standards will boost ability of fabrication facility to produce pilot-scale devices for NextFlex members…
22 Jul 19
The Ugandan government will support blockchain company MediConnect to explore using its technology to tackle the spread of…
18 Jul 19
Neuralink, based in San Francisco, has submitted for FDA approval for its data transmission system between people and…
16 Jul 19
Attivo Networks' Ms Carolyn Crandall shares significant steps for the healthcare industry to implement in its cybersecurity solutions…
11 Jul 19
A new study in the New England Journal of Medicine finds that rimegepant, a drug from a new…
11 Jul 19
PATH has developed a set of guidelines for developing and implementing artificial intelligence applications in healthcare.
28 Jun 19
B&S Healthcare is carrying out a recall for prescription drugs and the UK’s medicines regulator, the MHRA, has…
26 Jun 19
NuSight Medical announced that the US Patent Office has issued Patent No. 10,314,763, which is directed to methods…
The US Food and Drug Administration’s (FDA) Center for Devices and Radiological Health has undertaken significant steps to…